TrialInternational journal of clinical pharmacology and therapeutics2019
A PK/PD study comparing twice-daily to once-daily dosing regimens of ertugliflozin in healthy subjects .
Vikas Kumar Dawra et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this paperpooled ittrialcites it